Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 403.5 DKK -1.61% Market Closed
Market Cap: 1.8T DKK

Wall Street
Price Targets

NOVO B Price Targets Summary
Novo Nordisk A/S

There are no price targets for NOVO B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novo Nordisk A/S Competitors:
Price Targets
PPLPHARMA
Piramal Pharma Ltd
41% Upside
4530
Hisamitsu Pharmaceutical Co Inc
16% Upside
600535
Tasly Pharmaceutical Group Co Ltd
16% Upside
GSK
GlaxoSmithKline PLC
20% Upside
4536
Santen Pharmaceutical Co Ltd
47% Upside
SANOFI
Sanofi India Ltd
28% Upside
AHEALTH
Apex Healthcare Bhd
21% Upside

Revenue
Forecast

Revenue Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's revenue is 13%. The projected CAGR for the next 3 years is 16%.

13%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's operating income is 14%. The projected CAGR for the next 3 years is 16%.

14%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's net income is 13%. The projected CAGR for the next 3 years is 18%.

13%
Past Growth
18%
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVO B's stock price target?
Not Available

NOVO B doesn't have any price targets made by Wall Street professionals.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's revenue is 13%. The projected CAGR for the next 3 years is 16%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's operating income is 14%. The projected CAGR for the next 3 years is 16%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's net income is 13%. The projected CAGR for the next 3 years is 18%.

Back to Top